Mylan and Biocon file Herceptin biosimilar in Europe
First Herceptin biosimilar filed in EU, companies say.
X
Mylan and Biocon file Herceptin biosimilar in Europe
https://pharmaphorum.com/news/mylan-biocon-file-herceptin-biosimilar-europe/
Roche
Eleven seals deal with Roche on eye drug pipeline
Deal helps biotech to move on from phase 3 failures
England’s new-look Cancer Drugs Fund begins
But concerns remain about access to oncology medicines.
Genentech’s Xolair gets US paediatric use
Drug approved for asthma in children.
FDA fast-tracks review of Roche’s potential MS blockbuster
Regulator to make decision by year end.
UK trailing Europe on access to cancer drugs – report
UK has some of the lowest uptake of new cancer drugs.
Eye on ASCO Day 2 – Precision medicine takes centre stage
Data from one of the largest cancer genomics studies ever conducted.
